IL6 and neoplasm: In ccRCC tumors, IL-1β, IL-6, and TNF are essential inflammatory mediators that induce the activation of vascular endothelial cells and promoting angiogenesis, and high serum levels of these cytokines are associated with tumor progress (Díaz-Montero et al., 2020).